🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 191 of 200 · A–Z by INN

  1. tucatinib

    TUKYSA

    ORAL FDA: approved · EMA: approved

    L01EH03

  2. tucidinostat

    HIYASTA

    PMDA: approved

  3. turoctocog alfa

    NOVOEIGHT

    EMA: approved · PMDA: approved

    B02BD02

  4. turoctocog alfa pegol

    ESPEROCT

    EMA: approved

    B02BD02

  5. tuvonralimab

    NMPA: clinical trials

  6. twhf

    NMPA: clinical trials

  7. tyropanoate sodium

    BILOPAQUE

    ORAL FDA: approved

  8. tyrosine with carbohydrate

    TYROSINE 1000 Talion

    TGA: approved

  9. ublituximab

    BRIUMVI NEURAXPHARM AUSTRALIA PTY LIMITED

    EMA: approved · TGA: approved

    L04

  10. ublituximab-xiiy

    BRIUMVI TG THERAPEUTICS, INC.

    INTRAVENOUS FDA: approved

  11. ubrogepant

    UBRELVY

    ORAL FDA: approved

  12. udca

    NMPA: clinical trials

  13. ulinastatin

    NMPA: clinical trials

  14. ulipristal

    ESMYA

    EMA: withdrawn

    G03XB02

  15. ulipristal acetate

    ELLAONE Teva Pharma GmbH

    ORAL FDA: approved · EMA: approved

    G03AD02

  16. umbralisib tosylate

    UKONIQ

    ORAL FDA: approved

  17. umeclidinium

    INCRUSE ELLIPTA GlaxoSmithKline

    EMA: approved · TGA: approved

    R03BB07

  18. umeclidinium + vilanterol

    ANORO ELLIPTA 62.5/25 GlaxoSmithKline

    TGA: approved

  19. umeclidinium bromide

    ANORO ELLIPTA (PREVIOUSLY ANORO)

    INHALATION FDA: approved · EMA: approved

    R03AL03

  20. umeclidinium bromide/ vilanterol trifenatate

    ANORO ELLIPTA

    PMDA: approved

  21. unoprostone isopropyl

    RESCULA

    OPHTHALMIC FDA: approved

  22. upadacitinib

    RINVOQ AbbVie

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L04AA44

  23. upadacitinib hydrate

    RINVOQ PARTIAL CHANGE APPROVAL

    PMDA: approved

  24. uracil mustard

    URACIL MUSTARD

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources